CompletedPhase 4NCT06846255
Comparing DCP and DAP for Pemphigus Vulgaris
Studying Pemphigus vulgaris
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Jinnah Postgraduate Medical Centre
- Principal Investigator
- Zainab Javed, MBBS, APRN FNPJinnah Postgraduate Medical Centre
- Intervention
- Dexamethasone Cyclophosphamide Pulse therapy(drug)
- Enrollment
- 66 target
- Eligibility
- 20-60 years · All sexes
- Timeline
- 2021 – 2021
Study locations (1)
- Jinnah Postgraduate Medical Center, Karachi, Sindh, Pakistan
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06846255 on ClinicalTrials.govOther trials for Pemphigus vulgaris
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07384221Periodontal Status and Disease Severity in Pemphigus Vulgaris PatientsSaglik Bilimleri Universitesi
- RECRUITINGPHASE1, PHASE2NCT04422912A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)Cabaletta Bio
- RECRUITINGNCT02753777Autoimmune Blistering Diseases StudyUniversity of Pennsylvania